IRINOTECAN HYDROCHLORIDE INJECTION, 40 mg/2 mL (20 mg/mL), 2 mL Single Dose Vial, Rx only, Manufactured for: APP Pharmaceuticals, LLC, Schaumburg, IL 60173, NDC 63323-193-02, UPC 3 63323 19302 7.
Published August 28, 2013 · Recall initiated: January 22, 2013
Summary
FDA records drug Class II recall D-915-2013, published August 28, 2013 and initiated January 22, 2013. Recalling firm: Fresenius Kabi USA LLC (FK USA); Status: Terminated; Reported quantity: 23,672 vials; Lot: Lot #: 872CZ00101, Exp 12/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Crystallization: Active pharmaceutical ingredient is precipitating in product solution.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Fresenius Kabi USA LLC (FK USA)
- Distributor
- Nationwide
- Lot
- Lot #: 872CZ00101, Exp 12/13
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATagitol V Barium Sulfate Suspension (40% w/v, 30% w/w) Net Contents: 20 mL, (NDC 32909-814-53) Rx Only,August 28, 2013
- FDACLENZIderm M.D. Acne Therapeutic System Normal to Oily Skin kit, Distributed by OMP, Inc., Long Beach, CAAugust 28, 2013
- FDANystatin Oral Suspension, USP 500,000 units/ 5 mL (NDC 66689-037-01 ) Rx Only, Manufactured by VistaPharm,August 28, 2013
- FDAPenguinos - four cream filled chocolate cupcakes: gluten, wheat & dairy free & vegan; 4 x 2.2oz cupcakes, netAugust 28, 2013
- FDAEyebright Concentrate Topical Eye Rinse, 1, 2, 4, 8, 16 & 32 fl oz bottles, Produced and distributed by: WiseAugust 28, 2013
- FDACALCIUM GLUCONATE INJECTION, USP, 10% (100 mg/mL), 10 mL, Single Dose Vial, Rx only, For Direct Slow IV or IVMarch 20, 2013
Questions about this recall
Was IRINOTECAN HYDROCHLORIDE INJECTION, 40 mg/2 mL (20 mg/mL), 2 mL Single Dose Vial, Rx only, Manufactured for: APP Pharmaceuticals, LLC, Schaumburg, IL 60173, NDC 63323-193-02, UPC 3 63323 19302 7. recalled?
Yes. FDA published recall D-915-2013 on August 28, 2013. Reported hazard: Crystallization: Active pharmaceutical ingredient is precipitating in product solution.
What should I do if I have this product?
Voluntary: Firm initiated · Letter